drugset
drugset / Trial / NCT04673864

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386

NCT04673864 ↗

Phase 1 Completed 66 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A Clinical Trial to evaluate the Pharmacokinetics and Tolerability of CKD-386

Timeline

Start
2021-01-17
Primary completion
2021-03-04
Completion
2021-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-386 Unknown — Oral
Subject D012 Unknown — Oral
Subject D326 Unknown — Oral
Subject D337 Unknown — Oral

Indications

No indication recorded.